ArticleFrontiers in endocrinology2026
The diagnostic value and optimal cutoff of basal luteinizing hormone for central precocious puberty in premenarcheal girls stratified by weight status.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the diagnostic value and explore optimal cutoff value of the basal luteinizing hormone (LH) level for central precocious puberty (CPP) in premenarcheal girls with different weight status, so as to provide preliminary stratified reference thresholds and a basis for reducing unnecessary gonadotropin-releasing hormone (GnRH) stimulation tests in clinical screening. Methods: This retrospective single-center study involved girls with breast development. They were divided into groups of normal weight (n=982), overweight (n=381), obesity (n=195) and underweight (n=176) based on body mass index (BMI) z scores. All individuals underwent GnRH stimulation test. General characteristics and hormonal profiles were compared among different weight groups, and receiver operating characteristic (ROC) curves were plotted. Results: In each weight group, CPP girls had significantly higher basal LH, bone age, and uterine/ovarian volumes than non-CPP girls, and basal LH showed moderate positive correlations with peak LH (Spearman's rho ranged from 0.557 to 0.633, all P<0.05). Basal LH had a higher area under the curve (AUC) for CPP diagnosis than basal FSH and LH/FSH ratio across all groups, with the AUC values of basal LH being 0.770 (normal weight), 0.822 (overweight), 0.749 (obesity), and 0.767 (underweight). The optimal basal LH cutoffs derived from the maximum Youden index were 0.165 IU/L (normal weight), 0.145 IU/L (overweight), 0.135 IU/L (obesity) and 0.135 IU/L (underweight), with the corresponding Youden indices of 0.402, 0.525, 0.416, and 0.456, respectively. At these thresholds, the sensitivity of basal LH for CPP diagnosis ranged from 45.8% to 84.4% and specificity ranged from 63.6% to 70.4% across all subgroups. Conclusions: Basal LH serves as a convenient indicator with moderate diagnostic discrimination for CPP screening in premenarcheal girls with different weight statuses, and weight-stratified optimal cutoffs provide individualized screening references for girls with different weight statuses and help mitigate diagnostic bias caused by body weight confounding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.